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Abstract
Cellular barriers, such as the skin, the lung epithelium or the intestinal epithelium, constitute one of the first obstacles facing
nanomedicines or other nanoparticles entering organisms. It is thus important to assess the capacity of nanoparticles to enter and
transport across such barriers. In this work, Caco-2 intestinal epithelial cells were used as a well-established model for the intestinal
barrier, and the uptake, trafficking and translocation of model silica nanoparticles of different sizes were investigated using a com-
bination of imaging, flow cytometry and transport studies. Compared to typical observations in standard cell lines commonly used
for in vitro studies, silica nanoparticle uptake into well-developed Caco-2 cellular barriers was found to be very low. Instead, nano-
particle association to the apical outer membrane was substantial and these particles could easily be misinterpreted as internalised in
the absence of imaging. Passage of nanoparticles through the barrier was very limited, suggesting that the low amount of inter-
nalised nanoparticles was due to reduced uptake into cells, rather than a considerable transport through them.
Introduction
An overall conclusion from a multitude of nanoparticle-cell in
vitro studies is that nanoparticle uptake into cells is readily
achieved in most cell types, simply by exposing cells to media
containing nanoparticles. Preventing nanoparticles from
entering cells seems more challenging, though in the lab this
may be achieved by depleting cellular energy, thereby blocking
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active cellular pathways [1-3]. The unique capacity of nanopar-
ticles to enter cells, although promising for nanomedicine [4-9],
has caused concerns of nanosafety in relation to unintended
exposure to nanoparticles used in different technological appli-
cations (food additives, paintings, and others) [10-13].
Along different exposure routes, cellular barriers, such as the
skin, the lung epithelium, the intestinal epithelium or the
endothelium (including the blood-brain barrier), constitute one
of the first sites of interactions of nanoparticles, whether
intended as nanomedicines or not, with organisms. Thus in
addressing the potential use of nanoparticles for nanomedicine
or the potential hazards of nanomaterials, it is fundamental to
consider how nanoparticles interact, are processed by and trans-
ported across such barriers [14-16].
Specialised cellular layers also represent a more complex
system compared to single isolated cells commonly used for in
vitro studies. Indeed, cellular layers can develop tight junctions
and become polarised. Polarised cell barriers are known to acti-
vate cellular processes and pathways which are not fully de-
veloped, or even present, in isolated cells [17,18]. Thus they
allow investigation of nanoparticle-cell interactions in a situa-
tion closer to that in vivo.
Among several well established examples of in vitro cellular
layers, the human colon carcinoma epithelial cell line Caco-2
constitutes a reliable model of the intestinal barrier, which has
been widely used to predict function and bioavailability of com-
pounds in drug delivery. In vitro drug transport studies with
differentiated Caco-2 barriers are usually performed using tran-
swell systems that allow distinguishing the apical and basal side
of the developed monolayer, after polarisation and tight junc-
tion expression have been achieved [19-21].
Caco-2 cells have been used in the literature to investigate the
potential toxic effects of a range of nanoparticles, including
microporous silicon [22], silica [23-28] and zinc oxide [25].
Though such studies have mainly been performed on undiffer-
entiated cells, rather than Caco-2 barriers, interestingly, there
are suggestions that the response is different in overnight
cultures and cells grown for 10 days [25]. Uptake into Caco-2
cells has been reported for silica [23,24,26,28], polystyrene
[29], chitosan [30], poly(lactic-co-glycolic acid) [31-33] and
poly(lactic-co-glycolic acid) and poly(lactic acid) with attached
poly(ethylene glycol) [31,32] nanoparticles and to be tempera-
ture-dependent [29-33]. Despite uptake, transport across differ-
entiated Caco-2 barriers (grown for 21 days) has been shown to
be very limited for nanoparticles such as microporous silicon
[22], silica [23], poly(lactic-co-glycolic acid) [33] and carboxyl-
ated and aminated polystyrene [34].
We hypothesize that the low translocation observed in Caco-2
barriers results from a low uptake into the cells, an uptake that
depends on cellular differentiation and polarisation. Additional-
ly, though it is known that biomolecules adsorbed to nanoparti-
cles affect their cell adherence [35], uptake [26,35] and translo-
cation [34], we wish to clarify their role in the full process, from
adherence to translocation, in both undifferentiated and mature
Caco-2 barriers.
To this end, model silica nanoparticles of different sizes, for
which information on uptake and intracellular distribution in
typical in vitro cell lines is already available [36,37], were
exposed to differentiated Caco-2 barriers. In order to determine
the role of molecules adsorbed on the nanoparticles from the
surrounding environment, nanoparticle exposure was per-
formed in the absence and presence of foetal bovine serum as a
model biofluid. Indeed, it is crucial to utilize some type of
biofluid, because it has been shown that in its absence the high
surface energy of the bare nanoparticle surface may cause cell
damage [36,38]. This is unlikely to happen in any realistic
nanoparticle exposure scenario, where biomolecules adsorb to
the nanoparticle to form a nanoparticle biomolecular corona
which effectively protects the cells from such immediate
damage [39-41]. Though the intestinal lumen is not in direct
contact with blood serum, since the cells are normally cultured
in vitro in the presence of foetal bovine serum, we used foetal
bovine serum as a starting point of our work. Uptake into and
transport across the cellular barriers were investigated with a
combination of flow cytometry and fluorescence and electron
microscopy imaging. Transport studies across transwell
systems, typically used for the study of drug transport across
similar layers, were also applied. The combination of these dif-




Green fluorescent silica nanoparticles (SiO2-NPs) of 50 and
150 nm diameter were synthesized according to previous litera-
ture [42]. In order to remove eventual free fluorescent dye
releasing from the labelled nanoparticles [3,43,44], the nanopar-
ticle stocks were cleaned (by pelleting and resuspending in
fresh buffer) prior to experiments with cells. Sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) con-
firmed that for both nanoparticles, no labile dye was present in
the nanoparticle dispersions (Supporting Information File 1,
Figure S1). Based upon previous experience, we limited expo-
sure times to 6 hours in order to reduce the risk of released free
dye and fragmentation of the nanoparticles, stemming from
partial solubility in cell culture medium, which could confuse
uptake and transport studies [42].
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Table 1: Physicochemical characterisation of the 50 nm and 150 nm SiO2-NPs in different media. Nanoparticle dispersion (100 µg/mL) in water,
serum free HBSS and HBSS supplemented with 10% foetal bovine serum (FBS) were characterised by differential centrifugal sedimentation (DCS)
and dynamic light scattering (DLS) as described in the Experimental section. The table shows the apparent diameter and peak full width at half
maximum (FWHM) obtained by DCS, together with the results obtained by cumulant analysis of the DLS data (z-average diameter and polydispersity
index, PDI). The corresponding distributions are shown in Supporting Information File 1, Figures S2 and S3. For DLS results, errors represent stan-
dard deviation of 4 replicates (11 runs each).
Nanoparticle Medium DCS apparent
diameter (nm)
DCS FWHM (nm) Diameter (z-average,
nm)
PDI
50 nm SiO2 water 41 20 76a 0.159a
HBSS 44 23 79 ± 1b 0.17 ± 0.02b
HBSS, 10% FBS 50 27 102 ± 3c 0.42 ± 0.07c
150 nm SiO2 water 160, 183d 60d 154 ± 4 0.03 ± 0.03
HBSS 159, 181d 60d 190 ± 2 0.02 ± 0.01
HBSS, 10% FBS 149, 170d 60d 209 ± 2 0.18 ± 0.02
aData (for equivalent batch) reproduced from [42]. bThe presence of larger particles in the distribution of sizes (see DCS data in Supporting Informa-
tion File 1, Figure S3) will bias the DLS average towards larger sizes due to the stronger scattering from larger particles (the scattering intensity grows
strongly with particle size). cA second small peak around 10 nm due to the presence of proteins was also visible (Supporting Information File 1, Figure
S2) which explains the high average diameter and PDI. This was not visible for the larger particles, likely due to the substantially stronger scattering
stemming from them. dMultiple peaks were observed by DCS (Supporting Information File 1, Figure S3) and both peak positions are reported together
with the combined width.
Nanoparticle size and state of agglomeration in the different
media of interest were determined by differential centrifugal
sedimentation (DCS). The characterisation of one batch is
summarised in Table 1 (Supporting Information File 1, Figures
S2 and S3 show corresponding distributions). DCS of both
nanoparticles suspended in water shows that the sizes approxi-
mately matched the intended sizes, though the 150 nm
nanoparticles exhibited two populations (of similar size). In
Hank's balanced salt solution (HBSS), both in the absence and
presence of foetal bovine serum (FBS), DCS shows that the
samples remain dispersed, with no signs of agglomeration,
though naturally serum protein adsorption increases the sizes.
Table 1 also shows auxiliary dispersion characterisation by
dynamic light scattering (DLS), leading to the same conclu-
sions.
Nanoparticle dispersions were prepared with and without FBS
protein in order to test SiO2-NP uptake and interactions with the
Caco-2 barrier in the presence and absence of a nanoparticle
corona. The corona forming on the SiO2-NPs at different con-
centrations of serum was also characterised (Supporting Infor-
mation File 1, Figure S4) and results were in agreement with
previous findings on similar nanoparticles [45].
Formation and characterisation of Caco-2
barriers
Caco-2 cells were cultured on typical transwell systems for
21 days as described in the Experimental section, in order to
ensure formation of a polarised cell monolayer and develop-
ment of tight junctions [19,46,47]. Typical transmission elec-
tron microscopy (TEM) images of the obtained barriers are
shown in Supporting Information File 1, Figure S5. Cells with
the nuclei in a basal position and apical microvilli were ob-
served, and tight junctions were well expressed between the
confluent cells in the monolayer.
Transepithelial electrical resistance (TEER) was used to further
confirm barrier formation and test the integrity of the barriers
before and after exposure to the nanoparticles. TEER measure-
ments confirmed that the Caco-2 cell-monolayers exerted high
resistance values (up to 1000 Ω·cm2 on a 12-well transwell,
growth area 1.12 cm2) after 21 days of culture, comparable to
what has been reported in literature [46-48]. After exposure to
50 nm or 150 nm SiO2-NPs, only a small decrease in resistance
was observed (Supporting Information File 1, Figure S6),
suggesting no major effect of the particles on the overall barrier
integrity.
Nanoparticle uptake in Caco-2 barriers
cultured for 4 and 21 days
Flow cytometry was used to quantify cell fluorescence intensi-
ty due to association of the fluorescent SiO2-NPs with the cells.
In order to test if cell polarisation/differentiation plays a role in
controlling nanoparticle association with the Caco-2 barriers,
we performed this experiment after culturing the cells for 4 days
or 21 days. After 4 days of culture, Caco-2 cells reach complete
confluence, but their resistance is still low compared to their
21-day counterpart (Supporting Information File 1, Figure S7);
21 days of culture is needed for the full establishment of a
polarised barrier with fully developed tight junction expression.
We exposed the cultures to the two sizes of SiO2-NPs, in both
cases with an excess of particles compared to the number of
Beilstein J. Nanotechnol. 2017, 8, 1396–1406.
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Figure 1: 50 nm and 150 nm SiO2-NP association with Caco-2 barriers. Caco-2 barriers cultured for 4 and 21 days were exposed for 6 h to (a) 50 nm
and (b) 150 nm SiO2-NPs (100 µg/mL) in the absence and presence of 10% serum, prior to cell fluorescence measurements by flow cytometry.
Results are presented as the mean cell fluorescence intensity (due to nanoparticles) with error bars representing the standard error of the mean of 3
technical replicates (Supporting Information File 1, Figure S8 shows a comparison of three independent experiments). One may observe a general
trend of a larger nanoparticle association to barriers cultured for 4 days compared to those cultured for 21 days, as well as a trend of larger associa-
tion in the absence of serum. Note that the two nanoparticles are loaded with different amounts of fluorescent dye so no (direct) absolute comparison
may be made between the two sizes.
cells and at the same concentration (in mass per volume,
implying a different concentration in number per volume).
The cell fluorescence distributions obtained after exposure to
nanoparticles were rather broad (in comparison to what is ob-
served for similar particles in single cells [3,37]) indicating
rather different behaviours for cells within the same population.
Figure 1 shows a clear qualitative trend where Caco-2 barriers
cultured for 4 days exhibit a higher cell fluorescence intensity
compared to those cultured for 21 days under the same seeding
conditions. This is true regardless of the presence or absence of
serum, and regardless of the two particle sizes. Part of this
effect could be due to an increased packing of cells, mani-
festing itself as a decreased surface area per cell between 4 and
21 days, and thus a resulting lower association to the cell mem-
brane and consequent uptake. However, it is difficult to imagine
that this could amount to a difference that is sometimes as large
as an order of magnitude (cf. 150 nm SiO2 dispersed in serum-
free medium in Figure 1b). Furthermore, one may argue that the
development of microvilli in the barriers cultured for 21 days
increases the available surface area for contact with the
nanoparticles, thus counteracting the eventual decrease in
surface area due to increased packing of cells. This suggests
that the observation is likely a genuine effect of cell polarisa-
tion/differentiation and that indeed nanoparticle interactions
with well-developed cell layers can be very different compared
to what is observed in under-established cell barriers, even
when confluent.
Finally, cell association of nanoparticles dispersed in the
absence of serum is stronger compared to in the presence of
serum (Figure 1). This observation is consistent with literature,
where the presence of serum typically confers a lower associa-
tion with cells due to the formation of a biomolecular corona
[41] reducing the high surface energy of the bare particle sur-
face [36,38].
We next performed time resolved experiments (Supporting
Information File 1, Figure S9) where Caco-2 barriers (cultured
for 21 days) were exposed to nanoparticles for 6 h, the nanopar-
ticle source removed and the cells cultured for a further 4 h
prior to cell fluorescence measurement by flow cytometry (that
is, a 6 h “pulse” followed by a 4 h “chase”). In the majority of
cases, one observes (Supporting Information File 1, Figure S9)
a trend where the cell fluorescence decreases during the 4 h
without nanoparticles present, suggesting that the association of
nanoparticles with cells is (at least partly) only transient.
To better understand the observed behaviour and investigate
further particle uptake and localisation under the different
conditions, we turned to fluorescence imaging. Cell barrier
growth might be affected by different growth support material
[49], but culturing the Caco-2 barriers on a hard surface (cover-
slides) instead of a porous transwell, allows correlating the
imaging results to those coming from flow cytometry (where
the barriers were cultured in 12-well plates).
Figure 2 shows cross-sections taken from confocal imaging of
Caco-2 cell barriers cultured for 4 and 21 days following expo-
sure to 50 nm SiO2-NPs for 6 h. A first clear outcome is that, in
general, not many 50 nm SiO2-NPs (green) could be visualized
inside cells, regardless of polarisation/differentiation of the
Beilstein J. Nanotechnol. 2017, 8, 1396–1406.
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Figure 2: Confocal fluorescence cross-section images of Caco-2 barriers exposed to 50 nm SiO2-NPs. Caco-2 barriers cultured for 4 (a,b) and
21 days (c,d) were exposed for 6 h to 100 µg/mL 50 nm SiO2-NPs in the absence of serum (0% FBS; a and c) and presence of serum (10% FBS;
b and d). The nanoparticles are shown in green. Lysosomes and nuclei were stained by Lysosomal-Associated Membrane Protein 1 (LAMP1) anti-
body (red) and DAPI (blue), respectively.
cells. Rather, most nanoparticles were localized on the apical
cell membranes outside the cells. These observations allow us
to reconcile the results from flow cytometry showing a substan-
tial association of nanoparticles with cells during continuous
uptake (Figure 1) together with a loss of association after expo-
sure is stopped (Supporting Information File 1, Figure S9).
There is indeed a large association of nanoparticles with cells,
but this association is transient, because most nanoparticles are
not internalised but adhering to the outside of the cells [25,35]
and simply desorb once the nanoparticle source is removed. The
interpretation is then that the signal measured by flow cytom-
etry is largely coming from nanoparticles adhering to the
outside of the cells, rather than internalised. We note that sam-
ple processing before flow cytometric assessment may remove
some of the nanoparticles adhered on the outside of the cell.
Thus, the flow cytometry results are actually biased towards
showing a lower adsorbed amount, so the effect may actually be
larger than observed. In addition, the fact that a significant num-
ber of particles still remains adsorbed to cells suggests that the
adsorption is fairly strong, consistent with the slow desorption
process (Supporting Information File 1, Figure S9).
The lysosomes were also stained (LAMP1 antibody; red) as
previous studies have shown significant lysosomal colocalisa-
tion for several nanoparticle/cell systems [2,3,37,50]. Lyso-
somal staining showed that some of the (few) internalised nano-
particles were found in the lysosomes, and this was more
evident for the 50 nm SiO2-NPs in Caco-2 barriers cultured for
4 days compared to those cultured for 21 days.
Transmission electron microscopy (TEM) imaging was used to
further explore nanoparticle localisation in the Caco-2 barriers.
We confirmed that 6 h exposure led to very little internalisation
of particles in the Caco-2 barriers. In contrast, most of the ob-
served nanoparticles were found outside the cells, associated
with the microvilli (Supporting Information File 1, Figure S10).
This observation is clearly in agreement with the high amount
of fluorescence at the apical surface of the barriers seen using
light microscopy (Figure 2). It should be noted that such
particle association might be sensitive to the removal by
washing and other steps in the sample preparation procedure
for flow cytometry, which could explain the broad variability of
our flow cytometry data (Supporting Information File 1, Figure
S8).
Due to the low amount of SiO2-NPs internalised after 6 h, we
prolonged the exposure time to 9 h hoping for a better chance to
capture nanoparticle-related intracellular events. Some illustra-
tive images for 50 nm and 150 nm SiO2-NPs are shown in
Figure 3 and Figure 4, respectively. The particles are clearly
visible in electron microscopy due to their high density, as also
observed in our previous work [14,15,37,51]. Overall, consis-
tent with the above results, very few nanoparticles were found
inside the cells. Nevertheless, in the absence of serum, 50 nm
SiO2-NPs can be seen in the vicinity of microvilli (Figure 3a)
and a few nanoparticles were also found in lysosomes
(Figure 3b). For 50 nm SiO2-NPs dispersed in 10% serum,
nanoparticles were found enclosed in vesicles along the endo-
lysosomal pathways, including in endosomes (Figure 3c) and
lysosomes (Figure 3d and f). Furthermore, Figure 3e shows a
single nanoparticle within a vesicle close to the basolateral
membrane, where another vesicle has docked. Although rare,
we occasionally made such observations, both using TEM and
fluorescence microscopy (Supporting Information File 1, Figure
S11). Not wishing to overstate these observations, such vesic-
ular events may suggest rare events of transcytosis. Further
Beilstein J. Nanotechnol. 2017, 8, 1396–1406.
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Figure 3: Transmission electron micrographs of Caco-2 barriers after exposure to 50 nm SiO2-NPs. Caco-2 barriers cultured for 21 days were
exposed for 9 h to 100 µg/mL 50 nm SiO2-NPs dispersed in (a,b) the absence of serum, and (c–f) the presence of 10% FBS. The arrows indicate
some extracellular NPs and a few NPs observed inside the cells in different vesicles along the endolysosomal pathway. Abbreviations: E, endosome;
L, lysosome; V, vesicle.
studies need to be performed in order to fully address whether
or not rare transcytosis events may occur.
Some internalisation events were also seen for 150 nm SiO2-
NPs (Figure 4), with particles found in vesicles and lysosomes
in both 0 and 10% serum (Figure 4b and d, respectively) as de-
scribed for the smaller nanoparticles (Figure 3).
Finally, we performed transport studies to determine whether
the low amount of internalised nanoparticles observed by the
different microscopy methods was due to low uptake or fast
passage through the barrier. We found that the amount of SiO2-
NPs in the basolateral chamber was less than 1 wt % of the
applied apical dose, regardless of serum concentration or its
presence (Supporting Information File 1, Figure S12). Such a
low transport ratio is likely below the detection limit of the ex-
perimental setup, and our conclusion is simply that nanoparti-
cle transport across the barrier is negligible under all conditions
investigated, at least during this limited time-scale. This conclu-
sion is in agreement with other similar studies [22].
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Figure 4: Transmission electron micrographs of Caco-2 barriers after exposure to 150 nm SiO2-NPs. Caco-2 barriers cultured for 21 days were
exposed for 9 h to 100 µg/mL 150 nm SiO2-NPs dispersed in (a,b) the absence of serum, and (c,d) the presence of 10% FBS. The arrows indicate
extracellular NPs and some NPs inside vesicles along the endolysosomal pathway. Abbreviations: L, lysosome; TJs, tight junctions.
Conclusion
In the work presented here, we studied the interaction of model
silica nanoparticles with Caco-2 barriers. Nanoparticle associa-
tion with the Caco-2 barriers was considerably influenced by
the state of polarisation/differentiation of the cells, with a
consistently lower association of nanoparticles with polarised/
differentiated barriers (that is, with barriers cultured for 21
rather than 4 days). We argue that this effect cannot be ex-
plained solely by a reduction in exposed cell surface area when
a tight barrier is formed, and that the formation of microvilli
would anyway counteract such an effect by providing a larger
surface area for nanoparticle association. Thus the observation
seems to be a genuine biological response due to barrier polar-
isation/differentiation. Full development of an extracellular
matrix with mucus on the apical cell side could also constitute a
further obstacle for particle association with the barrier.
Furthermore, we found that the majority of nanoparticles asso-
ciated with the cells were adsorbed to the outer cell membranes,
rather than being internalised by the Caco-2 barriers. Thus,
results from flow cytometry exhibit a substantial signal which,
in isolation, could be misinterpreted for nanoparticle accumula-
tion, but which fluorescence and electron microscopy imaging
show is (predominantly) due to nanoparticle adsorption to the
outer cell membrane. Nevertheless, imaging shows some nano-
particle internalisation into the Caco-2 barriers, commonly
leading to lysosomal accumulation. Transport through the
barrier was found to be very low, suggesting that the low
amount of internalised nanoparticles was due to a low internali-
sation efficiency in the barriers rather than to a substantial trans-
port across it.
The low degree of internalisation is particularly striking in
comparison to our previous observations of a substantial uptake
of silica nanoparticles into (single) lung cells [37]. Moreover,
we have previously found sizable uptake of silica and poly-
styrene nanoparticles into another type of barrier, namely an in
vitro model of the human endothelial blood brain barrier
[14,15,51,52]. Thus, the low degree of uptake observed in the
Caco-2 barrier may be a characteristic of this type of barrier and
could be related to the more complex polarised nature of thicker
epithelial layers. Alternatively, it could be connected to the
presence of a rich extracellular matrix, which may increase
nanoparticle association to the apical side of the barrier, but also
impede further interactions with the actual cell membrane,
thereby lowering nanoparticle uptake.
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We note that our results are qualitative and that there remain
many interesting strands for future research. Thus the substan-
tial nanoparticle absorption to the outside of the cells is a
concern from a purely technical standpoint, potentially making
quantitative results highly dependent upon the nature of
washing and other sample preparation steps (indeed, we found
quantitative reproducibility to be an issue, as already noted).
Quantitative and detailed elucidation of the adsorption will have
to be based on more advanced methodology. Similarly, the
observation of a highly heterogeneous cell population is
interesting from a scientific point of view, but also complicates
the interpretation of imaging snapshots which do not sample all
the variation of the population. Again, a different methodology
will be needed to understand and capture this heterogeneity in
detail.
There could be broader implications of the low degree of inter-
nalisation into the Caco-2 barrier. In the context of nanomedi-
cine, the low internalisation could suggest that oral administra-
tion routes may lead to poor transport across the intestinal
epithelium. For nanosafety, toxic responses measured for single
cell cultures (where internalisation is usually substantial) may
have exaggerated effects which will not be present for real
barriers, where a lower dose is accumulated. On the other hand,
lower internalised doses have also been found to activate differ-
ent cellular pathways compared to those observed at higher
nanoparticle loads [53]. Thus the use of cellular barriers in
future could allow obtaining a more complete picture of the
possible outcomes of nanoparticle-cell interactions. Neverthe-
less, even when low internalisation is observed, it will be im-
portant to consider final fate of the internalised load, if export or
degradation are present, and potential effects of bioaccumula-
tion over chronic exposure.
Experimental
Nanoparticle characterisation
Green fluorescently labelled SiO2-NPs of 50 and 150 nm diam-
eters were synthesized in house according to previous literature
[42]. Particle dispersions were characterised at 100 µg/mL in
0% and 10% foetal bovine serum (FBS) in Hank's balanced salt
solution (HBSS) buffer (with 25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 7.4) at 25 °C, using
a Malvern Zetasizer Nano ZS90 (Worcestershire, UK) in order
to measure the hydrodynamic diameter by dynamic light scat-
tering (DLS). The 150 nm particles were also measured in
water. Further characterisation was performed using differen-
tial centrifugal sedimentation (DCS) on a CPS Disk Centrifuge
DC 24,000. A disc speed of 18,500 revolutions per minute
(RPM) was used and an 8–24% water or HBSS buffer sucrose
gradient was injected (settings optimized for size range analy-
sis 0.03–1 µm). A 476 nm polyvinyl chloride (PVC; Analytik
UK) commercial standard was used to calibrate the instrument
before each measurement. Each gradient was checked by
running the PVC standard as a sample and comparing to a data-
base control. 100 µL of standard was injected before each mea-
surement to calibrate the instrument, followed by 100 µL of the
undiluted particle dispersion.
Cell culture and exposure to nanoparticles
Caco-2 epithelial cells (supplied by European Collection of
Authenticated Cell Cultures) were cultured in complete
Dulbecco's Modified Eagle Medium (cDMEM) supplemented
with 10% FBS, 5 mL MEM non-essential amino acids (100 X),
5 mL Penicillin-Streptomycin (100 X, 10,000 units Penicillin
and 10,000 µg Streptomycin) in a cell incubator at 37 °C in a
humidified 5% CO2 atmosphere. Cells were trypsinised from
the flasks when 80–90% confluence was reached. For transwell
transport studies, 2 × 105 cells in 0.5 mL cDMEM were seeded
onto the apical chamber of a 3.0 μm poly(tetrafluoroethylene)
(PTFE) membrane insert (1.12 cm2 growth area), with 1.5 mL
cDMEM in the basolateral chamber. After 5–16 h in the cell
incubator, the apical medium was replaced by fresh cDMEM in
order to remove non-adherent cells and avoid formation of
multiple layers. Then the cells were grown a further 4 or
21 days, changing the medium in both chambers every second
day (in the first 15 days), or every day (from 15 to 21 days). A
layer of confluent cells was obtained after 4 days of culture; po-
larisation and tight junction expression were fully developed
after 21 days. For flow cytometry experiments, cells were
seeded in 12-well plates (approximately 3.9 cm2 growth area),
and the cell density adjusted for the larger growth area in order
to achieve similar growth conditions as for the transwell
systems. Caco-2 cells were then grown and maintained as de-
scribed above.
Prior to exposure to cells, as an additional precaution, the nano-
particle stocks were cleaned against the eventual presence of
free labile dye by centrifugation at 20,000 relative centrifugal
force (RCF) for 30 min, followed by resuspension in fresh
buffer and sonication for 3 min in a bath sonicator [42]. Caco-2
barriers were equilibrated in HBSS buffer at 37 °C for
30–60 min, and then exposed to the nanoparticle dispersions
both including and excluding 10% serum. Nanoparticle disper-
sions were freshly prepared by dilution to the final concentra-
tion for cell exposure (100 µg/mL) in HBSS buffer in the pres-
ence and absence of 10% FBS. Exposure to cells was per-
formed by replacement of the HBSS with the nanoparticle
dispersions.
Flow cytometry
Uptake studies by flow cytometry were carried out on Caco-2
barriers grown for 4 and 21 days on 12-well plates as described
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above. The 4 and 21 days old cultures were prepared so that
they were exposed on the same day to the same nanoparticle
dispersions. This limits variability due to nanoparticle disper-
sion and all steps of sample preparation for flow cytometry.
After exposure to 100 µg/mL nanoparticles dispersed in the
absence and presence of 10 % FBS, the dispersions were re-
moved from each well and cells were rinsed twice with fresh
phosphate buffered saline (PBS). Then, 1 mL 0.1% trypsin-
ethylenediaminetetraacetic acid (EDTA) solution was added
and the cells incubated at 37 °C, 5% CO2 humidified atmo-
sphere for 5–10 min to detach the cells. In some cases, where
the barrier cells were difficult to remove from the plates, a
second trypsinization was performed until the remaining cells
were completely detached, as determined by observation under
a light microscope. The detached cells were then collected from
each well and the same volume of complete medium added to
inhibit the trypsin. Cell pellets were harvested by centrifugation
at 1,500 RPM for 3 min and resuspended in fresh PBS. In order
to fix the cells, 4% formalin solution (Sigma-Aldrich) in PBS
was applied for 20 min and then replaced with PBS. Prior to
measurements by flow cytometry, cell samples were stabilised
at 4 °C for 1–2 h in darkness. Cell fluorescence intensity was
then acquired by flow cytometry using an Accuri C6 flow
cytometer (15,000 cells for each sample, after exclusion of cell
debris according to their forward and side scattering). The aver-
age values of the mean of the cell fluorescence distributions ob-
tained in this way (three replicates) were calculated, together
with the standard error of the mean (SEM), in order to deter-
mine nanoparticle uptake or association with cells.
Fluorescence imaging
Glass coverslips were sterilised in 70% ethanol and placed into
a 12-well plate. Caco-2 cells were seeded and grown for 4 and
21 days, as described above. After exposure to nanoparticles,
the nanoparticle dispersion was removed and cells rinsed with
PBS three times. Caco-2 cells were fixed and permeabilised
with methanol for 4 min at −20 °C and then carefully washed
with PBS three times. Antibody unspecific binding was
prevented by treating the cells with a blocking buffer of 1%
bovine serum albumin (BSA)-Tween PBS for 30 min (Tween
0.05%, v/v). To stain the lysosomes, cells were incubated with
LAMP-1 primary antibody (Abcam; dilution 1:100) for 1 h at
room temperature and then washed three times with PBS, prior
to incubation with Alexa 647 secondary antibody (Invitrogen;
dilution 1:300) under the same conditions. Cell nuclei were
stained by incubation with 4’,6-diamidino-2-phenylindole
(DAPI) for 5 min. The slides were then sealed by addition of
Mowiol mounting medium (Calbiochem) and stored at 4 °C
overnight. For image acquisition, tricolour visualization of cell
organelles, nanoparticles and nuclei, was performed on a
confocal microscope equipped with a CSU-X1 spinning disk
unit (Yokogawa Electric corporation), an iXon electron-multi-
plying charge-coupled device (EMCCD) camera (Andor,
Belfast, UK) and an inverted E-clipse microscope (Nikon,
Tokyo, Japan). SiO2-NPs were excited with a 488 nm laser line
(emission signal collected using a band pass 512 nm filter),
LAMP-1 with a 561 nm laser (emission light collected with a
long pass 624 nm filter) and DAPI with a 405 nm laser (emis-
sion light collected with a 448 nm filter). 40 X and 100 X
Olympus UPlanSAPO oil immersion objective lenses were
used. Images were acquired using Andor iQ2 software and
processed using Imaris imaging software (BitPlane, Zurich,
Switzerland).
Transmission electron microscopy
After exposure to the nanoparticles as described above, Caco-2
cell monolayers grown on 3.0 μm PTFE transwell membranes
were fixed with glutaraldehyde (2.5%, v/v) at room tempera-
ture for 1 h in Sorensen’s phosphate buffer, and post fixed in
osmium tetroxide (1%, w/v) in de-ionised water for 1 h. The
samples were rinsed in Sorensen’s phosphate buffer and dehy-
drated by incubation in 30%, 50%, 70%, 90% and 100%
ethanol solutions. The cells were immersed in ethanol/Epon
(1:1, v/v) mixture for 1 h before being transferred to pure Epon
and embedded at 37 °C for 2 h. The final polymerization was
carried out at 65 °C for 24 h. With a reported approach [16],
ultrathin sections of 80 nm, obtained with a diamond knife
using an ultramicrotome Leica U6, were mounted on copper
grids, and stained with 2% uranyl acetate and 0.4% lead citrate.
The sections were further examined at 120 kV with an FEI
TECNAI transmission electron microscope.
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